Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Rimm

Showing results (71-80 of 412) with videos related to

Pageof 42
Sort By:
Statistics in Medicine|December 13, 2021
Determination of the number of observers needed to evaluate a subjective test and its application in two PD-L1 studiesGang Han, Michael J Schell, Emily S Reisenbichler, et al.
NPJ Breast Cancer|February 13, 2020
Association between low estrogen receptor positive breast cancer and staining performanceDennis Caruana, Wei Wei, Sandra Martinez-Morilla, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 28, 2016
PD-L1 Expression in Lung CancerHui Yu, Theresa A Boyle, Caicun Zhou, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 17, 2017
Proof of the quantitative potential of immunofluorescence by mass spectrometryMaria I Toki, Fabiola Cecchi, Todd Hembrough, et al.
Cancer Journal (Sudbury, Mass.)|November 2, 2005
Immunohistochemical biomarkers in patients with early-onset breast carcinoma by tissue microarrayDoo Ho Choi, Sung Kim, David L Rimm, et al.
Breast Cancer Research : BCR|December 19, 2018
CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancersVasiliki Pelekanou, Franz Villarroel-Espindola, Kurt A Schalper, et al.
Breast Cancer Research and Treatment|June 4, 2008
Estrogen receptor co-activator (AIB1) protein expression by automated quantitative analysis (AQUA) in a breast cancer tissue microarray and association with patient outcomeMalini Harigopal, Jonas Heymann, Sriparna Ghosh, et al.
The Annals of Thoracic Surgery|November 25, 2004
Increased tissue microarray matrix metalloproteinase expression favors proteolysis in thoracic aortic aneurysms and dissectionsGeorge J Koullias, Pars Ravichandran, Dimitris P Korkolis, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 6, 2007
Quantitative analysis of estrogen receptor heterogeneity in breast cancerGina G Chung, Maciej P Zerkowski, Sriparna Ghosh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
Thyroid transcription factor 1 is an independent prognostic factor for patients with stage I lung adenocarcinomaValsamo K Anagnostou, Konstantinos N Syrigos, Gerold Bepler, et al.
Pageof 42

Showing results (71-80 of 412) with videos related to

Sort By:
Pageof 42
Statistics in Medicine|December 13, 2021
Determination of the number of observers needed to evaluate a subjective test and its application in two PD-L1 studiesGang Han, Michael J Schell, Emily S Reisenbichler, et al.
NPJ Breast Cancer|February 13, 2020
Association between low estrogen receptor positive breast cancer and staining performanceDennis Caruana, Wei Wei, Sandra Martinez-Morilla, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 28, 2016
PD-L1 Expression in Lung CancerHui Yu, Theresa A Boyle, Caicun Zhou, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 17, 2017
Proof of the quantitative potential of immunofluorescence by mass spectrometryMaria I Toki, Fabiola Cecchi, Todd Hembrough, et al.
Cancer Journal (Sudbury, Mass.)|November 2, 2005
Immunohistochemical biomarkers in patients with early-onset breast carcinoma by tissue microarrayDoo Ho Choi, Sung Kim, David L Rimm, et al.
Breast Cancer Research : BCR|December 19, 2018
CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancersVasiliki Pelekanou, Franz Villarroel-Espindola, Kurt A Schalper, et al.
Breast Cancer Research and Treatment|June 4, 2008
Estrogen receptor co-activator (AIB1) protein expression by automated quantitative analysis (AQUA) in a breast cancer tissue microarray and association with patient outcomeMalini Harigopal, Jonas Heymann, Sriparna Ghosh, et al.
The Annals of Thoracic Surgery|November 25, 2004
Increased tissue microarray matrix metalloproteinase expression favors proteolysis in thoracic aortic aneurysms and dissectionsGeorge J Koullias, Pars Ravichandran, Dimitris P Korkolis, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 6, 2007
Quantitative analysis of estrogen receptor heterogeneity in breast cancerGina G Chung, Maciej P Zerkowski, Sriparna Ghosh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
Thyroid transcription factor 1 is an independent prognostic factor for patients with stage I lung adenocarcinomaValsamo K Anagnostou, Konstantinos N Syrigos, Gerold Bepler, et al.
Pageof 42